Olli Vapalahti Selected Research

Olli Vapalahti Research Topics

Disease

58	Infections 04/2024 - 07/2002
19	Hantavirus Infections 03/2024 - 03/2003
18	COVID-19 03/2024 - 11/2020
12	Virus Diseases (Viral Diseases) 04/2024 - 10/2005
5	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 01/2024 - 09/2003
5	Vesicular Stomatitis 10/2023 - 01/2016
5	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2022 - 10/2004
4	Inflammation (Inflammations) 04/2024 - 11/2020
4	Pyoderma 01/2020 - 01/2014
3	Coinfection 01/2023 - 11/2018
3	Flavivirus Infections 01/2019 - 06/2014
3	Communicable Diseases (Infectious Diseases) 01/2016 - 08/2012
3	Japanese Encephalitis 12/2013 - 09/2012
2	Necrosis 04/2024 - 11/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2019
2	Hepatitis 01/2020 - 08/2003
2	Hemorrhage 12/2019 - 07/2002
2	Tick Bites 01/2018 - 05/2008
2	Zika Virus Infection 01/2018 - 03/2017
2	Arthritis (Polyarthritis) 01/2016 - 01/2008
2	Dengue (Dengue Fever) 11/2014 - 01/2010
2	Cowpox 04/2014 - 11/2003
1	Liver Diseases (Liver Disease) 04/2024
1	Ataxia Neuropathy Spectrum 04/2024
1	Epilepsy (Aura) 04/2024
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 02/2024
1	Cognitive Dysfunction 02/2024
1	Alzheimer Disease (Alzheimer's Disease) 02/2024
1	Severe Acute Respiratory Syndrome 02/2024
1	Thrombocytopenia (Thrombopenia) 11/2023
1	Measles 01/2023
1	Tetanus 01/2023
1	Diphtheria 01/2023
1	Olfaction Disorders (Cacosmia) 01/2023
1	Rheumatoid Arthritis 01/2023
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023
1	Amnesia (Dissociative Amnesia) 01/2023
1	Noncommunicable Diseases 07/2022
1	Proteinuria 01/2022

Drug/Important Bio-Agent (IBA)

24	AntibodiesIBA 02/2024 - 09/2003
18	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2007
17	VaccinesIBA 11/2023 - 05/2008
15	Immunoglobulin M (IgM)IBA 01/2020 - 03/2003
13	AntigensIBA 01/2021 - 07/2002
12	Immunoglobulin G (IgG)IBA 01/2023 - 11/2003
11	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2005
7	Antiviral Agents (Antivirals)IBA 04/2024 - 03/2017
6	EnzymesIBA 03/2024 - 03/2003
6	Viral RNAIBA 12/2023 - 07/2008
6	Glycoproteins (Glycoprotein)IBA 10/2023 - 06/2008
5	Neutralizing AntibodiesIBA 02/2024 - 01/2021
5	Peptides (Polypeptides)IBA 10/2022 - 06/2014
4	CytokinesIBA 01/2024 - 01/2020
4	Complement System Proteins (Complement)IBA 01/2023 - 08/2012
4	21-fluoro-16-ethyl-19-norprogesterone (FENP)IBA 01/2020 - 01/2014
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 10/2004
3	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2011
3	Phosphotransferases (Kinase)IBA 07/2023 - 08/2021
3	nafamostatIBA 07/2023 - 08/2021
3	apilimodIBA 07/2023 - 08/2021
3	SARS-CoV-2 spike proteinIBA 10/2022 - 01/2021
3	Peptide Hydrolases (Proteases)FDA Link 06/2022 - 08/2021
3	EpitopesIBA 01/2019 - 06/2014
2	ImmunosorbentsIBA 03/2024 - 02/2008
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2024 - 10/2003
2	Monoclonal AntibodiesIBA 10/2023 - 01/2022
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	camostatIBA 10/2021 - 08/2021
2	CathepsinsIBA 10/2021 - 08/2021
2	AutoantibodiesIBA 01/2019 - 08/2012
2	SuspensionsIBA 10/2017 - 01/2017
2	Gemcitabine FDA Link 03/2017 - 10/2012
2	saliphenylhalamideIBA 03/2017 - 10/2012
2	obatoclaxIBA 03/2017 - 10/2012
2	NucleoproteinsIBA 01/2017 - 01/2015
2	Viral AntigensIBA 08/2012 - 07/2002
2	Caspase 8 (Caspase-8)IBA 03/2005 - 11/2004
1	DNA Polymerase gammaIBA 04/2024
1	Mitochondrial DNA (mtDNA)IBA 04/2024
1	Mitochondrial RNAIBA 04/2024
1	Interferon Type IIBA 04/2024
1	COVID-19 VaccinesIBA 03/2024
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2024
1	Single-Domain AntibodiesIBA 02/2024
1	Particulate MatterIBA 02/2024
1	Air Pollutants (Pollutants, Air)IBA 02/2024
1	Angiotensin-Converting Enzyme 2IBA 12/2023
1	Nucleocapsid ProteinsIBA 12/2023
1	Neuropilin-1IBA 12/2023
1	1-Phosphatidylinositol 4-Kinase (1 Phosphatidylinositol 4 Kinase)IBA 07/2023
1	Drug CombinationsIBA 07/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2023
1	Serine Proteases (Serine Protease)IBA 07/2023
1	Glutamic Acid (Glutamate)FDA Link 01/2023
1	ToxoidsIBA 01/2023
1	morpholinopropane sulfonic acid (MOPS)IBA 01/2023
1	Nasal SpraysIBA 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022

Therapy/Procedure

5	Therapeutics 02/2024 - 03/2017
1	Intranasal Administration 01/2023